Persistent Elevation of Parathyroid Hormone during Pediatric Parathyroidectomy

Abstract

Primary hyperparathyroidism due to adenoma or hyperplasia is often the cause of inappropriately elevated parathyroid hormone in patients with hypercalcemia. Intraoperative monitoring of parathyroid hormone serum concentrations is widely accepted in the adult population, ensuring adequate resection during primary operative exploration. Here, we describe a pediatric case report during which intraoperative hormone monitoring was crucial in directing the operative approach. This symptomatic patient had standard preoperative studies. However, despite an adequate resection of the identified hyperactive tissue, her intraoperative parathyroid hormone concentrations remained inappropriately elevated prompting further dissection of neighboring tissue. A parathyroid adenoma was successfully excised during the operation, preventing further invasive procedures. This report highlights the feasibility of monitoring intraoperatively parathyroid hormone levels in the pediatric population.

Keywords

intraoperative parathyroid hormone - adenoma - hyperparathyroidism

• References

• 1 Risteil J, Winter WE, Kleerekoper M, Risteil L. Bone and mineral metabolism. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 5th ed. St. Louis, MO: Elsevier Saunders; 2012: 1733-1801
• 2 Root AW, Diamond FB. Disorders of mineral homeostasis in children and adolescents. In: Sperling M, ed. Pediatric Endocrinology. 4th ed. Philadelphia, PA: Elsevier Saunders; 2014: 734-845
• 3 Hortin GL, Carter AB ; College of American Pathologists Point-of-Care Testing Resource Committee. Intraoperative parathyroid hormone testing: survey of testing program characteristics. Arch Pathol Lab Med 2002; 126 (9) 1045-1049
• 4 College of American Pathologists Proficiency Testing Program (CAP PT) surveys 2014 Y-A ligands (special). Available at: http://viewer.zmags.com/publication/b12dd13c#/b12dd13c/1 . Accessed December 20, 2014.
• 5 Burke JF, Chen H, Gosain A. Parathyroid conditions in childhood. Semin Pediatr Surg 2014; 23 (2) 66-70
• 6 Calò PG, Pisano G, Loi G , et al. Intraoperative parathyroid hormone assay during focused parathyroidectomy: the importance of 20 minutes measurement. BMC Surg 2013; 13: 36
• 7 Sharma J, Milas M, Berber E, Mazzaglia P, Siperstein A, Weber CJ. Value of intraoperative parathyroid hormone monitoring. Ann Surg Oncol 2008; 15 (2) 493-498
• 8 Richards ML, Thompson GB, Farley DR, Grant CS. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg 2011; 146 (3) 280-285
• 9 Lee S, Ryu H, Morris LF , et al. Operative failure in minimally invasive parathyroidectomy utilizing an intraoperative parathyroid hormone assay. Ann Surg Oncol 2014; 21 (6) 1878-1883
• 10 Locchi F, Cavalli T, Giudici F, Brandi ML, Tonelli F. Intraoperative PTH monitoring: a new approach based on the identification of the “true” time origin of the decay curve. Endocr J 2014; 61 (3) 239-247
• 11 Çelik A, Divarcı E, Dökümcü Z , et al. Intraoperative parathyroid hormone monitoring corroborates the success of parathyroidectomy in children. J Clin Res Pediatr Endocrinol 2014; 6 (3) 158-162